Cargando…

Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility

BACKGROUND: Xpert MTB/RIF assay is considered as a great advance over conventional smear and culture in the diagnosis of TB and MDR-TB by simultaneously detecting M.tuberculosis and rifampicin resistance bacilli. However, very little information regarding the performance characteristics of Xpert MTB...

Descripción completa

Detalles Bibliográficos
Autores principales: Geleta, Dereje Assefa, Megerssa, Yoseph Cherinet, Gudeta, Adugna Negussie, Akalu, Gizachew Taddesse, Debele, Melaku Tesfaye, Tulu, Kassu Desta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615882/
https://www.ncbi.nlm.nih.gov/pubmed/26483194
http://dx.doi.org/10.1186/s12866-015-0566-6
_version_ 1782396527231107072
author Geleta, Dereje Assefa
Megerssa, Yoseph Cherinet
Gudeta, Adugna Negussie
Akalu, Gizachew Taddesse
Debele, Melaku Tesfaye
Tulu, Kassu Desta
author_facet Geleta, Dereje Assefa
Megerssa, Yoseph Cherinet
Gudeta, Adugna Negussie
Akalu, Gizachew Taddesse
Debele, Melaku Tesfaye
Tulu, Kassu Desta
author_sort Geleta, Dereje Assefa
collection PubMed
description BACKGROUND: Xpert MTB/RIF assay is considered as a great advance over conventional smear and culture in the diagnosis of TB and MDR-TB by simultaneously detecting M.tuberculosis and rifampicin resistance bacilli. However, very little information regarding the performance characteristics of Xpert MTB/RIF assay is available in Ethiopia. Therefore, the purpose of this study was to evaluate the performance of Xpert MTB/RIF assay compared to conventional sputum smear and culture methods for the diagnosis of pulmonary tuberculosis in remote health care facility. METHODS: A paired expectorated sputum samples were obtained from 227 consecutively recruited patients with signs and symptoms suggestive of tuberculosis at Karamara hospital during December 2013 to May 2014. One of the sputum specimen was tested directly by Ziehl-Neelsen staining and Xpert MTB/RIF assay without NALC-NaOH decontamination. The other of pair of sputa specimen was cultured for isolation of TB bacilli by conventional methods. Diagnostic performance of Xpert MTB/RIF assay and AFB smear microscopy were calculated against culture as the gold standard. RESULTS: Overall 25.5 % (58/227) samples were positive for Mycobacterium tuberculosis complex (MTBC) by MGIT and/or LJ media of which 36.2 % (21/58) and 65.5 % (35/58) were positive by AFB smear microscopy and Xpert MTB/RIF respectively. The sensitivity, specificity, as well as the positive and negative predictive value of Xpert MTB/RIF assay were 65.5 % (95 % CI: 53.3–77.7 %), 96.3 % (95 % CI: 93.4–99.2 %), 86.4 % (95 % CI: 76.2–96.5 %), and 88.6 % (95 % CI: 83.9–93.3 %) respectively. Eighteen of 58 (31 %) cases that were smear microscopy negative, were positive by Xpert MTB/RIF assay. CONCLUSIONS: Although Xpert MTB/RIF assay demonstrated high sensitivity in detecting MTBC in sputum specimens compared with conventional AFB smear microscopy, it demonstrated suboptimal sensitivity in smear negative patients compared to conventional culture.
format Online
Article
Text
id pubmed-4615882
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46158822015-10-23 Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility Geleta, Dereje Assefa Megerssa, Yoseph Cherinet Gudeta, Adugna Negussie Akalu, Gizachew Taddesse Debele, Melaku Tesfaye Tulu, Kassu Desta BMC Microbiol Research Article BACKGROUND: Xpert MTB/RIF assay is considered as a great advance over conventional smear and culture in the diagnosis of TB and MDR-TB by simultaneously detecting M.tuberculosis and rifampicin resistance bacilli. However, very little information regarding the performance characteristics of Xpert MTB/RIF assay is available in Ethiopia. Therefore, the purpose of this study was to evaluate the performance of Xpert MTB/RIF assay compared to conventional sputum smear and culture methods for the diagnosis of pulmonary tuberculosis in remote health care facility. METHODS: A paired expectorated sputum samples were obtained from 227 consecutively recruited patients with signs and symptoms suggestive of tuberculosis at Karamara hospital during December 2013 to May 2014. One of the sputum specimen was tested directly by Ziehl-Neelsen staining and Xpert MTB/RIF assay without NALC-NaOH decontamination. The other of pair of sputa specimen was cultured for isolation of TB bacilli by conventional methods. Diagnostic performance of Xpert MTB/RIF assay and AFB smear microscopy were calculated against culture as the gold standard. RESULTS: Overall 25.5 % (58/227) samples were positive for Mycobacterium tuberculosis complex (MTBC) by MGIT and/or LJ media of which 36.2 % (21/58) and 65.5 % (35/58) were positive by AFB smear microscopy and Xpert MTB/RIF respectively. The sensitivity, specificity, as well as the positive and negative predictive value of Xpert MTB/RIF assay were 65.5 % (95 % CI: 53.3–77.7 %), 96.3 % (95 % CI: 93.4–99.2 %), 86.4 % (95 % CI: 76.2–96.5 %), and 88.6 % (95 % CI: 83.9–93.3 %) respectively. Eighteen of 58 (31 %) cases that were smear microscopy negative, were positive by Xpert MTB/RIF assay. CONCLUSIONS: Although Xpert MTB/RIF assay demonstrated high sensitivity in detecting MTBC in sputum specimens compared with conventional AFB smear microscopy, it demonstrated suboptimal sensitivity in smear negative patients compared to conventional culture. BioMed Central 2015-10-19 /pmc/articles/PMC4615882/ /pubmed/26483194 http://dx.doi.org/10.1186/s12866-015-0566-6 Text en © Geleta et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Geleta, Dereje Assefa
Megerssa, Yoseph Cherinet
Gudeta, Adugna Negussie
Akalu, Gizachew Taddesse
Debele, Melaku Tesfaye
Tulu, Kassu Desta
Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title_full Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title_fullStr Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title_full_unstemmed Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title_short Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
title_sort xpert mtb/rif assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615882/
https://www.ncbi.nlm.nih.gov/pubmed/26483194
http://dx.doi.org/10.1186/s12866-015-0566-6
work_keys_str_mv AT geletaderejeassefa xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility
AT megerssayosephcherinet xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility
AT gudetaadugnanegussie xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility
AT akalugizachewtaddesse xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility
AT debelemelakutesfaye xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility
AT tulukassudesta xpertmtbrifassayfordiagnosisofpulmonarytuberculosisinsputumspecimensinremotehealthcarefacility